RE: InvestorMeet5 Nov 2024 13:41
As we know, there's no fast adoption in the NHS. Bleepa has a foot in the odd door, but no stonking contracts, e.g QVH only 900k instead of headline £1.6m.
The ERF was there in 2021. Where was Feedback then?
Clearly there's an opportunity now, but can the current team deliver? That's my issue, a lot of noise, and glacial adoption.
Is Tom the man to get the SP back to the dizzy heights of £1.80?